Filing Details

Accession Number:
0001179110-17-012323
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-09-15 15:51:41
Reporting Period:
2017-09-13
Accepted Time:
2017-09-15 15:51:41
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
855654 Immunogen Inc IMGN Pharmaceutical Preparations (2834) 042726691
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1177813 Craig Barrows 22 Chesnut Street
Salem MA 01970
Executive Vp, General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-09-13 20,000 $4.50 51,100 No 4 M Direct
Common Stock Disposition 2017-09-13 14,600 $6.95 36,500 No 4 S Direct
Common Stock Acquisiton 2017-09-15 30,000 $4.50 66,500 No 4 M Direct
Common Stock Disposition 2017-09-15 22,450 $6.73 44,050 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2017-09-13 20,000 $4.50 20,000 $4.50
Common Stock Stock Option (right to buy) Disposition 2017-09-15 30,000 $4.50 30,000 $4.50
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
30,000 2008-10-03 2017-10-03 No 4 M Direct
0 2008-10-03 2017-10-03 No 4 M Direct
Footnotes
  1. Exercisable as to 12,500 shares commencing on October 3, 2008, 12,500 shares commencing on October 3, 2009, 12,500 shares commencing on October 3, 2010 and 12,500 shares commencing on October 3, 2011.
  2. Weighted average price of shares sold.